Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 11.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
10.75 11.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 14.52 -1.27 -0.10 38
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 11.00 GBX

Kromek (KMK) Latest News

More Kromek News
Kromek Takeover Rumours

Kromek (KMK) Discussions and Chat

Kromek Forums and Chat

Date Time Title Posts
19/9/202006:11Kromek Group PLC3,493
21/8/201710:01Kromek Group (KMK) - Overvalued AIM mugging181

Add a New Thread

Kromek (KMK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-09-21 15:25:3211.0828,0003,102.09O
2020-09-21 15:25:2010.7610,0001,076.00O
2020-09-21 15:24:2810.7815,0001,617.00O
2020-09-21 15:23:4710.7810,0001,078.00O
2020-09-21 15:08:0511.005,000550.13O
View all Kromek trades in real-time

Kromek (KMK) Top Chat Posts

DateSubject
21/9/2020
09:20
Kromek Daily Update: Kromek Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 11p.
Kromek Group Plc has a 4 week average price of 11.75p and a 12 week average price of 11.75p.
The 1 year high share price is 27.25p while the 1 year low share price is currently 9.15p.
There are currently 344,559,089 shares in issue and the average daily traded volume is 1,170,160 shares. The market capitalisation of Kromek Group Plc is £37,901,499.79.
04/9/2020
13:58
sev22: Simon Thompson wrote the article below 4 months ago. This morning the shares have dropped to 13.0p which seems a massive over reaction to no news. Kromek’s valuable IP materially undervalued. A trading update from Kromek (KMK:17.5p), a radiation detection technology company focused on the medical, security screening and nuclear markets, prompted a 12 per cent share price markdown that simply isn’t warranted. True, Covid-19 restrictions means that two key contracts will be postponed until the new financial year, the impact of which is that Kromek will break even on a cash profit basis in the 12 months to 30 April 2020. However, the contracts have only been delayed, not lost. There is clearly demand for its products as highlighted by the massive ventilator order I commented on in mid-April (‘Stockpicking for bear market gains’, 16 Apr 2020). Moreover, analyst Paul Hill at Equity Development points out that Kromek is well advanced on its US Department of Defence contract to develop a groundbreaking vehicle biological threat detector that rapidly detects any airborne pathogen used in germ warfare. Mr Hill understands that the “same first-of-its-kind science can also accurately and consistently recognise Covid-19” and could have “substantial benefits for many non-military applications, such as shopping centres, sports arenas, theme parks, schools, hospitals, offices, airplanes, and cruise ships”. This is certainly not being priced in, nor is the real possibility of additional ventilator orders. The shares offer 100 per cent upside to my 35p target price. Buy.
03/8/2020
18:55
sev22: The write-up below was the last time Simon Thompson highlighted Kromek as a small-cap value play and was featured in the 7th - 14th of May 2020 edition of the Investors Chronicle. The closing price on Monday means there is well over 100% upside to his target price of 35p. Kromek’s valuable IP materially undervalued: A trading update from Kromek (KMK:17.5p), a radiation detection technology company focused on the medical, security screening and nuclear markets, prompted a 12 per cent share price markdown that simply isn’t warranted. True, Covid-19 restrictions means that two key contracts will be postponed until the new financial year, the impact of which is that Kromek will break even on a cash profit basis in the 12 months to 30 April 2020. However, the contracts have only been delayed, not lost. There is clearly demand for its products as highlighted by the massive ventilator order I commented on in mid-April (‘Stockpicking for bear market gains’, 16 Apr 2020). Moreover, analyst Paul Hill at Equity Development points out that Kromek is well advanced on its US Department of Defence contract to develop a groundbreaking vehicle biological threat detector that rapidly detects any airborne pathogen used in germ warfare. Mr Hill understands that the “same first-of-its-kind science can also accurately and consistently recognise Covid-19” and could have “substantial benefits for many non-military applications, such as shopping centres, sports arenas, theme parks, schools, hospitals, offices, airplanes, and cruise ships”. This is certainly not being priced in, nor is the real possibility of additional ventilator orders. The shares offer 100 per cent upside to my 35p target price. Buy.
11/2/2020
23:48
kr01: Considering that this Miton fund is a forced seller dealing with redemptions - and the market knows this - the share price is holding up pretty well. Clearly being supported, bodes well... GLA
07/2/2020
13:07
alangriffbang: Don’t take any notice of this village idiot ,he has posted On the IDE site a good report and guess what he share price is down , he deserves a medal for the worst tipster ,
02/1/2020
11:59
mrnumpty: I notice that the great share-sage " chimers " is now blessing the Bango chat-site with his pronouncements . Well, here , back on 4th December 2019 , when Kromek's share price hit its nadir of 15.25p , " chimers " informed us that " it [ Kromek ] might hit 13p to sell TODAY " . At the moment , Kromek's share price , at 25p/26p , has virtually doubled .
13/12/2019
10:41
mrnumpty: Another great vindication of the sage pronouncements of " chimers " ( deep irony ) !!! This person inhabits far too many Aim chat sites and all that we can do is spread the message regarding him / her / it in order to warn those who have not previously encountered him . Unfortunately , although I was a holder in Kromek , I sold out some while ago but , despite noticing that it had recently dropped to about 15.25 p , I didn't buy back in . Anyway , congratulations to those , wiser , more experienced , or luckier than me , who are profiting from this sudden upswing in the share price .
25/11/2019
09:10
quepassa: Some share price performance mile-stones. As at today:- 1. 12 month low 2. 3 year low 3. 5 year low 4. All-time low. ALL IMO. DYOR. QP
17/9/2019
11:36
mrnumpty: As someone who has held Kromek , but who sold some months ago , I have been watching the share price as I might buy back in . A couple of thoughts occur to me . Firstly , although the Company is growing well and has huge potential , the share price barely moves , having been about 25p for some time . However , a fan on Kromek is Simon Thomson , the share tipster of Investors' Chronicle . I have noticed that several of his tips have recently been bought out , and it seems to me that a larger predator , especially with the UK £ so low , might pounce on Kromek . My second observation is that , according to information on the Hargreaves Lansdowne site ( which might not be fully up-to-date , I acknowledge ) , Kromek is the biggest holding , at 4.06 % of the total fund size , of LF Miton UK Smaller Companies unit trust . Obviously a quick glance at the price of this fund will show that it hasn't done well recently , but that is evidently because UK smaller companies in general are seen as more vulnerable to any damage caused by Brexit . No doubt " chimers " and co will greet this with their usual charm , but I prefer to maintain the dignity of Boris Johnson in the face of the puerile offensiveness of what's-his-name , the prime minister of mighty Luxembourg ( apologies in advance to any Luxemburgers here who are susceptible to micro-aggressions ) . .
26/7/2019
15:41
varies: Well done the Investors Chronicle. Their recommendation seems to have no effect until lunchtime but we see a rise of over 10% since. As usual the price will probably soon drift down again but I feel we shall arrive at a point soon where the share price can manage a sustained advance.
12/4/2017
07:34
hyperboreus: Not wishing to comment on anything that has gone before but ST did in fact reply yesterday to patient_investor regarding Kromek in his comments section basically just reiterating his current stance on the Company: 1:17 PM on 11/4/2017 Hi Simon, Please could you provide your thoughts on KMK share price returning to 26.40p, a fall of some 30% since their inevitable spike in the aftermath of your tip? Do you still rate the shares a "strong buy"? Regards Patient SIMONTHOMPSON 1:36 PM on 11/4/2017 Patient I advised buying Kromek shares at 25p on Monday, 27 February after which almost 12 million shares traded in 689 bargains in the following two days. The weight of money continued to chase the shares and this meant that the share price moved up 36 per cent from 25.5p on the offer at 12pm on Monday 27 February to a high of 34.9p on Tuesday 7 March. In my analysis I stated that: "From my lens, the bottom is now in place and a break-out above the 25p resistance is highly likely, suggesting a sharp move to the 30p resistance level that halted progress last summer. Beyond that analyst's 34p a share price targets come firmly into play." I can't blame anyone for taking a 36 per cent profit in the space of a week. I would also mention that the Daily Telegraph subsequently tipped the shares which accentuated the rise and a fair amount of that buying was hot money, hence the subsequent fall. Nothing has changed in terms of the investment case as I still believe that 34p a share is fair value. I would flag up that subsequent to my article, on 24 March 2017, Berry Beumer, Chief Operating Officer of Kromek, purchased 80,000 Ordinary Shares at a price of 29.35 pence per share. Also, Kromek has also been awarded a contract, valued at $990k, by an existing US-based customer, a global leader in aerospace and defence technologies, for the upgrade of the Company's advanced security screening detectors that the customer has deployed since 2009. I believe the shares rate a buy at 26p. I hope this clarifies matters. Best wishes
Kromek share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
KMK
Kromek
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200922 06:04:20